期刊文献+

Toll样受体9基因多态性与重症肌无力相关性研究

Correlation between Toll-like receptor 9 gene polymorphism and myasthenia gravis
下载PDF
导出
摘要 目的探讨Toll样受体9(Toll-like receptor 9,TLR9)基因rs352140和rs187084位点多态性与重症肌无力(myasthenia gravis,MG)的相关性。方法纳入109例MG患者和162例健康体检者。采用聚合酶链反应-限制性内切酶多态性方法对TLR9基因rs352140和rs187084位点分型,并在MG组与对照组、MG各亚组(性别、发病年龄、胸腺情况、最严重时Osserman分型、Oosterhuis评分和激素近期疗效)与对照组、MG各亚组之间比较两位点等位基因频率和共显性、加性、过显性遗传模型下基因型频率的差异。结果 TLR9基因rs352140和rs187084位点等位基因频率和共显性、加性、过显性遗传模型下的基因型频率在MG组与对照组、MG各亚组与对照组及MG各亚组之间差异无统计学意义(P>0.05)。结论 TLR9基因rs352140和rs187084位点多态性与重症肌无力的易感性、严重程度和激素疗效无相关性。 Objective To investigate the correlation between Toll-like receptor 9( TLR9)polymorphism and the susceptibility,severity and short-term effect of glucocorticoid in myasthenia gravis( MG) patients. Methods One hundred and nine MG patients and 162 healthy controls in Han Chinese population were enrolled. Subgroups were divided by gender,onset age,thymoma status,Osserman type, Oosterhuis score and short-term effect of glucocorticoid. Rs352140 and rs187084 were genotyped by polymerase chain reaction-based restriction fragment length polymorphism( PCR-RFLP) method. Allele frequencies and genotype frequencies( under codominant,logadditive and over-dominant mode of inheritance) were compared between MG / control group,MG subgroups / control group and each pairs of MG subgroups. Results In rs352140 and rs187084,there were no significant differences in allele frequencies and genotype frequencies( under codominant,log-additive and over-dominant mode of inheritance) among MG / control group,MG subgroups / control group and MG subgroups( P > 0. 05). Conclusion No correlation was found between rs352140 and rs187084 polymorphisms and the susceptibility,severity and short-term effect of glucocorticoid in myasthenia gravis patients.
出处 《转化医学杂志》 2016年第1期19-23,共5页 Translational Medicine Journal
基金 国家自然科学基金(81070963) 山东省自然科学基金资助(ZR2010HM019)
关键词 重症肌无力 TOLL样受体9 基因多态性 Myasthenia gravis Toll like receptor 9(TLR9) Gene polymorphism
  • 相关文献

参考文献19

  • 1Tao Kayoko,Fujii Mutsuko,Tsukumo Shin-ichi,Maekawa Yoichi,Kishihara Kenji,Kimoto Yasutaka,Horiuchi Takahiko,Hisaeda Hajime,Akira Shizuo,Kagami Shoji,Yasutomo Koji.Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Annals of the Rheumatic Diseases . 2007
  • 2Cavalcante Paola,Maggi Lorenzo,Colleoni Lara,Caldara Rosa,Motta Teresio,Giardina Carmelo,Antozzi Carlo,Berrih-Aknin Sonia,Bernasconi Pia,Mantegazza Renato.Inflammation and epstein-barr virus infection are common features of myasthenia gravis thymus: possible roles in pathogenesis. Autoimmune diseases . 2011
  • 3Ichikawa HT,Williams LP,Segal BM.Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol . 2002
  • 4Iwasaki A,Medzhitov R.Toll-like receptor control of the adaptive immune responses. Nature Immunology . 2004
  • 5Etem Ebru Onalan,Elyas Halit,Ozgocmen Salih,Y?ld?r?m Arefe,Godekmerdan Ahmet.The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatology International . 2010
  • 6Hong Jiwon,Leung Euphemia,Fraser Alan G,Merriman Tony R,Vishnu Prakash,Krissansen Geoffrey W.TLR2, TLR4 and TLR9 polymorphisms and Crohn’s disease in a New Zealand Caucasian cohort. Journal of Gastroenterology . 2007
  • 7Y. H. Lee,H. -S. Lee,S. J. Choi.Associations between TLR polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY . 2012
  • 8DavidGrob,NormanBrunner,TatsujiNamba,MuraliPagala.??Lifetime course of myasthenia gravis(J)Muscle Nerve . 2008 (2)
  • 9Philip Deitiker,Tetsuo Ashizawa,M.Zouhair Atassi.??Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptor act as initial triggers of myasthenia gravis?(J)Human Immunology . 2000 (3)
  • 10Liao Wen-Ling,Chen Rong-Hsing,Lin Hui-Ju,Liu Yu-Huei,Chen Wen-Chi,Tsai Yuhsin,Wan Lei,Tsai Fuu-Jen.Toll-like receptor gene polymorphisms are associated with susceptibility to graves’ ophthalmopathy in Taiwan males. BMC Medical Genetics . 2010

二级参考文献34

  • 1Sun J, Walsh M, Villarino A V, et al. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development [J ]. J Immnol, 2005, 174(2) : 742-751.
  • 2Takeda K, Kaisho T, Akira S. Toll-like receptors [ J ]. Annu Rev Immunol, 2003, 21 (4) .. 335-376.
  • 3Lafon M, Megret F, Lafage M, etal. The innate immune facet of brain : human neurons express TLR-3 and sense viral dsRNA[ J]. J Mol Neurosci, 2006, 29(3) : 185-194.
  • 4Jack C S, Arbour N, Blain M, et al. Thl polarization of CD4^+T cells by Toll-like receptor 3-activated human microglia[ J]. J Neuropathol Exp Neurol, 2007, 66 (9) : 848 -859.
  • 5Ichikawa H T, Williams L P, Segal B M. Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease [ J ]. J Immunol,2002, 169(5) :2781-2787.
  • 6Raimondi G, Turner M S, Thomson A W, et al. Naturally occurring regulatory T cells : recent insights in health and disease[J]. Crit Rev lrnmunol, 2007, 27(1) :61-95.
  • 7Prinz M, Garbe F, Schmidt H, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis [ J ] . J Clin Invest, 2006 , 116 ( 2 ) : 454 -464.
  • 8Smit L A, Siroux V, Bouzigon E, et al. CD14 and toll-like receptor gene polymorphisms, country living, and asthma in adults[ J]. Am J Respir Crit Care Med, 2009, 179 (5) :363-368.
  • 9Polman C H, Reingold S C, Edan G, et al. Diagnostic criteria for multiple sclerosis : 2005 revisions to the " McDonald Criteria" [J]. Ann Neurol, 2005, 58(6) : 840-846.
  • 10Ueta M, Sotozono C, Inatomi T, et al. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome[J]. Br J Ophthalmol, 2007, 91 (7) : 962- 965.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部